Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-05-12 Ryder Sean General Counsel Sale −4,475 $2.92 $13K 47,621
2025-03-14 Ryder Sean General Counsel Grant or award +10,708 52,096
2024-12-18 Ryder Sean General Counsel Grant or award +22,000 41,388
2024-12-18 Ryder Sean General Counsel Grant or award · Stock Option (right to buy) +30,000 30,000
2024-06-24 Ryder Sean General Counsel Sale −5,496 $2.12 $12K 19,388
2024-05-29 Ryder Sean General Counsel Purchase +10,000 10,572
2024-05-29 Ryder Sean General Counsel Purchase · Common Stock Warrant (Right to Buy) +10,000 10,000
2024-03-14 Ryder Sean General Counsel Grant or award +9,270 22,778
2024-02-19 Ryder Sean General Counsel Grant or award +2,936 13,508
2023-09-20 Ryder Sean General Counsel Exercise or conversion +10,000 $6.00 $60K 10,572
2023-09-20 Ryder Sean General Counsel Sale −10,000 $30.00 $300K 572
2023-09-20 Ryder Sean General Counsel Exercise or conversion · Stock Option (right to buy) −10,000 140,000
2023-09-11 Ryder Sean General Counsel Grant or award · Stock Option (right to buy) +40,000 40,000
2023-08-18 Ryder Sean General Counsel Sale −328 $23.73 $8K 572
2023-02-17 Ryder Sean General Counsel Grant or award +900 900

Page 1 of 1 · 15 trades